Skip to main content
. Author manuscript; available in PMC: 2014 Nov 14.
Published in final edited form as: Leuk Res. 2013 Jul 25;37(11):1440–1444. doi: 10.1016/j.leukres.2013.07.007

Table 3.

Therapy Related Toxicities in Patients Who Received Pomalidomide 3.0 mg/day (N = 21)

Side Effects Grade 1 Grade 2 Grade 3 Grade 4
Rash, Itching 5 1
Hypersensitivity reaction 2
Fatigue, weakness 1
Sensory Neuropathy 1
Neutropenia 4 4
Anemia 1 5 2
Thrombocytopenia 2